V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017162 | 160016534 | 0 | 91.9 | null | null | 2020-08-12 | Niraparib | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + OBINUTUZUMAB + VINCRISTINE | 100936393 |
| 160017164 | 160016535 | 1.55 | 69.6 | Palliative (P) | 2019-11-18 | 2019-11-19 | MELPHALAN | N | Y | STS RHABDO RMS 2005 VIN CYCLO | 100139910 |
| 160017165 | 160016536 | 1.83 | 81.8 | Palliative (P) | 2017-10-18 | 2018-08-16 | NB HRNBL-1 COJEC Ind COURSE C | 02 | null | IVA | 100739403 |
| 160017166 | 160016537 | 1.68 | 73.6 | Neo-adjuvant (N) | 2019-02-20 | 2019-03-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101531354 |
| 160017174 | 160016538 | 0 | 64 | Palliative (P) | 2018-08-08 | 2019-03-05 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | DACARBAZINE + GEMCITABINE | 100074163 |
| 160017176 | 160016539 | 1.79 | 94 | null | 2019-06-04 | 2019-06-05 | Gemcitabine day 1&8 | 02 | null | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100445707 |
| 160017179 | 160016540 | 1.87 | 19.9 | 03 | null | 2014-08-10 | null | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100043144 |
| 160017182 | 160016541 | 1.72 | 47.6 | null | 2021-05-31 | 2021-07-04 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | null | PEMBROLIZUMAB | 100369669 |
| 160017183 | 160016542 | 1.79 | 56.7 | null | 2018-03-02 | 2018-07-13 | CONFIRM TRIAL | 02 | null | OLAPARIB | 100209716 |
| 160017186 | 160016543 | 0 | 9.9 | Neo-adjuvant (N) | 2018-10-05 | 2019-01-04 | Cisplatin + Etoposide (5 day) | 01 | N | EW EUROEWING 2012 ARM B IE | 101204364 |
| 160017187 | 160016544 | null | 69.1 | Neo-adjuvant (N) | 2019-06-26 | 2019-07-17 | Doxorubicin + Ifosfamide | 01 | N | RUCAPARIB | 100982620 |
| 160017190 | 160016545 | 0 | 97.1 | null | 2018-09-30 | 2019-04-14 | Trial Unspecified | 02 | null | OLAPARIB | 101300246 |
| 160017194 | 160016546 | 1.6 | 86.2 | Palliative (P) | 2019-02-14 | 2019-03-04 | Olaratumab | 01 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101188298 |
| 160017196 | 160016547 | 0 | 59.5 | Neo-adjuvant (N) | 2017-10-29 | 2018-03-24 | PROMISE-MESO TRIAL | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100729238 |
| 160017199 | 160016548 | 1.82 | 15.4 | null | 2018-06-25 | 2018-07-05 | EW EuroEwing 2012 Arm B IE | 02 | null | EURO-EWING | 100719924 |
| 160017200 | 160016549 | 1.69 | 85 | Neo-adjuvant (N) | 2018-06-12 | 2019-07-05 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | TAZEMETOSTAT | 101515987 |
| 160017212 | 160016550 | 1.73 | 66 | Curative (C) | 2018-04-01 | 2018-11-27 | VINCRISTINE | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 101707123 |
| 160017219 | 160016552 | 1.85 | null | null | 2016-10-26 | 2016-10-27 | CONFIRM TRIAL | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101529211 |
| 160017220 | 160016553 | 1.71 | null | null | 2016-10-07 | 2016-10-07 | Cyclophosphamide oral | 02 | null | CARBOPLATIN + VINORELBINE | 101402976 |
| 160017222 | 160016554 | 1.62 | 74 | Neo-adjuvant (N) | 2018-11-11 | 2019-09-26 | Enzalutamide | 99 | N | GEMCITABINE | 100311295 |
| 160017227 | 160016555 | 1.72 | 53.8 | null | 2018-08-02 | 2018-08-14 | null | N | null | DOXORUBICIN + IFOSFAMIDE | 100296549 |
| 160017234 | 160016556 | 1.61 | 60 | null | 2018-10-12 | 2019-06-04 | Doxorubicin + Ifosfamide | 02 | null | NOT MATCHED | 101628809 |
| 160017245 | 160016558 | 0 | 17.4 | null | 2019-05-18 | 2019-05-18 | GEMCITABINE | null | null | LANREOTIDE | 100445502 |
| 160017246 | 160016559 | 0 | 28.25 | Palliative (P) | 2018-01-27 | 2018-02-06 | STS Rhabdo VIT0910 Vinc Irino Temoz | Y | N | TOPOTECAN | 100598433 |
| 160017247 | 160016560 | 0 | 71.8 | null | 2020-11-28 | 2020-12-29 | EW EuroEwing 2012 Arm B VC | 02 | null | TEMOZOLOMIDE | 100922074 |
| 160017251 | 160016561 | 1.65 | 85.7 | Curative (C) | 2018-01-08 | 2018-02-01 | CONFIRM TRIAL | 02 | N | FLUOROURACIL + OXALIPLATIN | 101434073 |
| 160017255 | 160016562 | 1.15 | 62 | Palliative (P) | 2017-04-26 | 2017-05-22 | BUSULFAN + MELPHALAN | 01 | N | EW EUROEWING 2012 ARM B VDC/IE | 100161502 |
| 160017257 | 160016563 | 1.62 | 74.7 | Curative (C) | 2018-12-30 | 2019-01-07 | Gemcitabine day 1&8 | 02 | null | TOPOTECAN | 100397247 |
| 160017258 | 160016564 | 1.78 | 98.7 | Palliative (P) | 2019-09-09 | 2019-09-24 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | EW EUROEWING 2012 ARM A/B BUMEL | 100638043 |
| 160017260 | 160016565 | 1.64 | 14.6 | null | 2020-01-22 | 2020-02-13 | PEMBROLIZUMAB | 01 | null | GEMCITABINE | 100969350 |
| 160017276 | 160016566 | 1.72 | 73 | null | 2017-12-07 | 2018-01-09 | EW EuroEwing 2012 Arm A VAI | 99 | null | NB HRNBL-1 COJEC IND COURSE B | 100469645 |
| 160017277 | 160016567 | 0 | 46.4 | Adjuvant (A) | 2019-10-05 | 2019-10-20 | Trial Unspecified | 02 | N | ETOPOSIDE | 100030899 |
| 160017287 | 160016568 | 1.87 | 17.4 | Curative (C) | 2016-09-27 | 2017-02-27 | CVP R | Y | N | GEMCITABINE | 101651506 |
| 160017297 | 160016570 | 1.62 | 69.6 | null | null | 2019-10-22 | IPM | 02 | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 101018565 |
| 160017298 | 160016571 | 1.7 | 17.8 | null | 2019-04-18 | 2019-07-17 | DACARBAZINE + GEMCITABINE | N | null | RUCAPARIB | 101191782 |
| 160017299 | 160016572 | 1.7 | 99.7 | Curative (C) | null | 2016-12-16 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | Y | EURO-EWING | 100029304 |
| 160017314 | 160016573 | 1.72 | 38 | Curative (C) | 2017-09-27 | 2017-09-27 | Carboplatin + Vinorelbine IV &PO D8 | 2 | N | TRIAL | 101633755 |
| 160017317 | 160016574 | 0 | 73 | Curative (C) | 2020-01-10 | 2020-02-22 | Trial Unspecified | 2 | N | NIRAPARIB | 101618593 |
| 160017318 | 160016575 | 1.62 | 19.3 | Curative (C) | 2019-01-23 | 2019-03-07 | GEMCITABINE | Y | N | EW EUROEWING 2012 ARM B IE | 100679489 |
| 160017321 | 160016576 | 1.71 | 20 | null | 2016-05-24 | 2016-06-13 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | STS NON-RHABDO EPSSG 2005 IVA | 101584698 |
| 160017323 | 160016577 | 1.86 | 68.6 | Curative (C) | 2016-11-23 | 2016-12-24 | ETOP 13-18 BEAT-meso Trial | N | Y | CARBOPLATIN + VINORELBINE | 101178515 |
| 160017328 | 160016578 | 1.63 | 84.5 | Neo-adjuvant (N) | 2020-03-17 | 2020-03-27 | PROMISE-MESO TRIAL | 2 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101659424 |
| 160017330 | 160016579 | 0 | 96.75 | Palliative (P) | 2018-09-11 | 2018-09-18 | IPO | 02 | N | ANTIBODY NBL | 101791368 |
| 160017331 | 160016580 | 0 | 66 | Curative (C) | 2020-01-27 | 2020-01-27 | Olaparib | 02 | Y | ETOPOSIDE + RITUXIMAB | 100683540 |
| 160017337 | 160016582 | 1.6 | 89 | Palliative (P) | 2019-03-07 | 2019-03-08 | Ifosfamide | 02 | N | OLARATUMAB | 100402879 |
| 160017339 | 160016583 | 1.23 | 81.6 | Palliative (P) | 2020-02-02 | 2020-09-03 | Gemcitabine day 1&8 | 02 | N | NIRAPARIB | 101225579 |
| 160017354 | 160016584 | 1.82 | 82.4 | Palliative (P) | 2017-04-13 | 2017-06-13 | Dacarbazine | 02 | N | NOT MATCHED | 101603955 |
| 160017358 | 160016585 | 1.62 | 74 | Curative (C) | null | 2017-07-27 | Dacarbazine | null | Y | CARBOPLATIN + VINORELBINE | 100480278 |
| 160017360 | 160016586 | 1.58 | 56.2 | null | 2016-11-21 | 2016-11-21 | Abiraterone | 02 | null | EW EUROEWING 2012 ARM A VAI | 100725871 |
| 160017362 | 160016587 | 1.69 | 34 | 03 | 2018-03-13 | 2018-12-26 | NB HRNBL-1 BUMEL MAT | 02 | null | IPILIMUMAB | 101168777 |